I also agree. In my opinion, analytical issues have lots of problems specific for structure of nitrosamines, features of API and drug products, including sample preparations, improvement of sensitivity, mitigation of false positive signals, routine tests vs option4, reference standards… To be honest, I have no idea how to share them appropriately, however I believe we can start discussion whenever we want.
@JohannesReiner
The following thread may be similar to your suggestion. And I agree with your thought, both are definitely important!!